BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34513524)

  • 21. Microbiota dysbiosis and myasthenia gravis: Do all roads lead to Rome?
    Kapoor B; Gulati M; Gupta R; Singla RK
    Autoimmun Rev; 2023 May; 22(5):103313. PubMed ID: 36918089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of Caesarean section on the infant gut microbiome.
    Hoang DM; Levy EI; Vandenplas Y
    Acta Paediatr; 2021 Jan; 110(1):60-67. PubMed ID: 33405258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
    Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
    Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota in common elderly diseases affecting activities of daily living.
    Shimizu Y
    World J Gastroenterol; 2018 Nov; 24(42):4750-4758. PubMed ID: 30479462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism.
    Hu S; Ding Q; Zhang W; Kang M; Ma J; Zhao L
    Gut Microbes; 2023; 15(1):2236749. PubMed ID: 37559394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Microbiota and Breast Cancer-Is There Any Relevant Link?-A Literature Review and New Horizons Toward Personalised Medicine.
    Alpuim Costa D; Nobre JG; Batista MV; Ribeiro C; Calle C; Cortes A; Marhold M; Negreiros I; Borralho P; Brito M; Cortes J; Braga SA; Costa L
    Front Microbiol; 2021; 12():584332. PubMed ID: 33716996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
    Zhou Z; Sun B; Yu D; Zhu C
    Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiome and Development of Ovarian Cancer.
    Dhingra A; Sharma D; Kumar A; Singh S; Kumar P
    Endocr Metab Immune Disord Drug Targets; 2022; 22(11):1073-1090. PubMed ID: 35532247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human gut microbiota/microbiome in health and diseases: a review.
    Gomaa EZ
    Antonie Van Leeuwenhoek; 2020 Dec; 113(12):2019-2040. PubMed ID: 33136284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut Microbiota and Obesity: A Role for Probiotics.
    Abenavoli L; Scarpellini E; Colica C; Boccuto L; Salehi B; Sharifi-Rad J; Aiello V; Romano B; De Lorenzo A; Izzo AA; Capasso R
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31703257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.
    Cuevas-Sierra A; Ramos-Lopez O; Riezu-Boj JI; Milagro FI; Martinez JA
    Adv Nutr; 2019 Jan; 10(suppl_1):S17-S30. PubMed ID: 30721960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
    Amabebe E; Robert FO; Agbalalah T; Orubu ESF
    Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Our Little Friends with Big Roles: Alterations of the Gut Microbiota in Thyroid Disorders.
    Ejtahed HS; Angoorani P; Soroush AR; Siadat SD; Shirzad N; Hasani-Ranjbar S; Larijani B
    Endocr Metab Immune Disord Drug Targets; 2020; 20(3):344-350. PubMed ID: 31566142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
    Yurtdaş G; Akdevelioğlu Y
    J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycystic Ovary Syndrome and Endometrial Cancer: A Scoping Review of the Literature on Gut Microbiota.
    Prakash A; Nourianpour M; Senok A; Atiomo W
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotics, prebiotics and colorectal cancer prevention.
    Ambalam P; Raman M; Purama RK; Doble M
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal vitamin D receptor protects against extraintestinal breast cancer tumorigenesis.
    Zhang YG; Xia Y; Zhang J; Deb S; Garrett S; Sun J
    Gut Microbes; 2023; 15(1):2202593. PubMed ID: 37074210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.